Intensive referral to 12-step dual-focused mutual-help groups.
Identifieur interne : 001562 ( Main/Exploration ); précédent : 001561; suivant : 001563Intensive referral to 12-step dual-focused mutual-help groups.
Auteurs : Christine Timko [États-Unis] ; Anne Sutkowi ; Ruth C. Cronkite ; Kerry Makin-Byrd ; Rudolf H. MoosSource :
- Drug and alcohol dependence [ 1879-0046 ] ; 2011.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Diagnostic mixte (psychiatrie) (MeSH), Femelle (MeSH), Groupes d'entraide (MeSH), Humains (MeSH), Mâle (MeSH), Orientation vers un spécialiste (MeSH), Résultat thérapeutique (MeSH), Thérapie cognitive (MeSH), Troubles liés à une substance (psychologie), Troubles liés à une substance (thérapie), Troubles mentaux (psychologie), Troubles mentaux (thérapie).
- MESH :
- psychologie : Troubles liés à une substance, Troubles mentaux.
- thérapie : Troubles liés à une substance, Troubles mentaux.
- Adulte, Adulte d'âge moyen, Diagnostic mixte (psychiatrie), Femelle, Groupes d'entraide, Humains, Mâle, Orientation vers un spécialiste, Résultat thérapeutique, Thérapie cognitive.
English descriptors
- KwdEn :
- Adult (MeSH), Cognitive Behavioral Therapy (MeSH), Diagnosis, Dual (Psychiatry) (MeSH), Female (MeSH), Humans (MeSH), Male (MeSH), Mental Disorders (psychology), Mental Disorders (therapy), Middle Aged (MeSH), Referral and Consultation (MeSH), Self-Help Groups (MeSH), Substance-Related Disorders (psychology), Substance-Related Disorders (therapy), Treatment Outcome (MeSH).
- MESH :
Abstract
BACKGROUND
This study implemented and evaluated procedures to help clinicians effectively refer dually diagnosed (substance use and psychiatric disorders) patients to dual-focused mutual-help groups (DFGs).
METHODS
Using a cohort cyclical turnover design, individuals with dual diagnoses beginning a new outpatient mental health treatment episode (N=287) entered a standard- or an intensive-referral condition. Participants provided self-reports of 12-step mutual-help (DFG and substance-focused group [SFG]) attendance and involvement and substance use and psychiatric symptoms at baseline and six-month follow-up. The intensive referral intervention focused on encouraging patients to attend DFG meetings.
RESULTS
Compared to patients in the standard condition, those in the intensive referral intervention were more likely to attend and be involved in DFGs and SFGs, and had less drug use and better psychiatric outcomes at follow-up. Attending more intensive-referral sessions was associated with more DFG and SFG meeting attendance. More need fulfillment in DFGs, and more readiness to participate in SFGs, were associated with better alcohol and psychiatric outcomes at six months. However, only 23% of patients in the intensive-referral group attended a DFG meeting during the six-month follow-up period.
CONCLUSIONS
The intensive referral intervention enhanced participation in both DFGs and SFGs and was associated with better six-month outcomes. The findings suggest that intensive referral to mutual-help groups focus on its key components (e.g., linking patients to 12-step volunteers) rather than type of group.
DOI: 10.1016/j.drugalcdep.2011.03.019
PubMed: 21515004
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Intensive referral to 12-step dual-focused mutual-help groups.</title>
<author><name sortKey="Timko, Christine" sort="Timko, Christine" uniqKey="Timko C" first="Christine" last="Timko">Christine Timko</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Health Care Evaluation, Department of Veterans Affairs Health Care System, and Stanford University Medical Center, 795 Willow Road (152-MPD), Menlo Park, CA 94025, USA. ctimko@stanford.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Health Care Evaluation, Department of Veterans Affairs Health Care System, and Stanford University Medical Center, 795 Willow Road (152-MPD), Menlo Park, CA 94025</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sutkowi, Anne" sort="Sutkowi, Anne" uniqKey="Sutkowi A" first="Anne" last="Sutkowi">Anne Sutkowi</name>
</author>
<author><name sortKey="Cronkite, Ruth C" sort="Cronkite, Ruth C" uniqKey="Cronkite R" first="Ruth C" last="Cronkite">Ruth C. Cronkite</name>
</author>
<author><name sortKey="Makin Byrd, Kerry" sort="Makin Byrd, Kerry" uniqKey="Makin Byrd K" first="Kerry" last="Makin-Byrd">Kerry Makin-Byrd</name>
</author>
<author><name sortKey="Moos, Rudolf H" sort="Moos, Rudolf H" uniqKey="Moos R" first="Rudolf H" last="Moos">Rudolf H. Moos</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21515004</idno>
<idno type="pmid">21515004</idno>
<idno type="doi">10.1016/j.drugalcdep.2011.03.019</idno>
<idno type="wicri:Area/Main/Corpus">001565</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001565</idno>
<idno type="wicri:Area/Main/Curation">001565</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001565</idno>
<idno type="wicri:Area/Main/Exploration">001565</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Intensive referral to 12-step dual-focused mutual-help groups.</title>
<author><name sortKey="Timko, Christine" sort="Timko, Christine" uniqKey="Timko C" first="Christine" last="Timko">Christine Timko</name>
<affiliation wicri:level="2"><nlm:affiliation>Center for Health Care Evaluation, Department of Veterans Affairs Health Care System, and Stanford University Medical Center, 795 Willow Road (152-MPD), Menlo Park, CA 94025, USA. ctimko@stanford.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Health Care Evaluation, Department of Veterans Affairs Health Care System, and Stanford University Medical Center, 795 Willow Road (152-MPD), Menlo Park, CA 94025</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sutkowi, Anne" sort="Sutkowi, Anne" uniqKey="Sutkowi A" first="Anne" last="Sutkowi">Anne Sutkowi</name>
</author>
<author><name sortKey="Cronkite, Ruth C" sort="Cronkite, Ruth C" uniqKey="Cronkite R" first="Ruth C" last="Cronkite">Ruth C. Cronkite</name>
</author>
<author><name sortKey="Makin Byrd, Kerry" sort="Makin Byrd, Kerry" uniqKey="Makin Byrd K" first="Kerry" last="Makin-Byrd">Kerry Makin-Byrd</name>
</author>
<author><name sortKey="Moos, Rudolf H" sort="Moos, Rudolf H" uniqKey="Moos R" first="Rudolf H" last="Moos">Rudolf H. Moos</name>
</author>
</analytic>
<series><title level="j">Drug and alcohol dependence</title>
<idno type="eISSN">1879-0046</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Cognitive Behavioral Therapy (MeSH)</term>
<term>Diagnosis, Dual (Psychiatry) (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Mental Disorders (psychology)</term>
<term>Mental Disorders (therapy)</term>
<term>Middle Aged (MeSH)</term>
<term>Referral and Consultation (MeSH)</term>
<term>Self-Help Groups (MeSH)</term>
<term>Substance-Related Disorders (psychology)</term>
<term>Substance-Related Disorders (therapy)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Diagnostic mixte (psychiatrie) (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Groupes d'entraide (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Orientation vers un spécialiste (MeSH)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Thérapie cognitive (MeSH)</term>
<term>Troubles liés à une substance (psychologie)</term>
<term>Troubles liés à une substance (thérapie)</term>
<term>Troubles mentaux (psychologie)</term>
<term>Troubles mentaux (thérapie)</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Troubles liés à une substance</term>
<term>Troubles mentaux</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Mental Disorders</term>
<term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Mental Disorders</term>
<term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Troubles liés à une substance</term>
<term>Troubles mentaux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Cognitive Behavioral Therapy</term>
<term>Diagnosis, Dual (Psychiatry)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Referral and Consultation</term>
<term>Self-Help Groups</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Diagnostic mixte (psychiatrie)</term>
<term>Femelle</term>
<term>Groupes d'entraide</term>
<term>Humains</term>
<term>Mâle</term>
<term>Orientation vers un spécialiste</term>
<term>Résultat thérapeutique</term>
<term>Thérapie cognitive</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b>
</p>
<p>This study implemented and evaluated procedures to help clinicians effectively refer dually diagnosed (substance use and psychiatric disorders) patients to dual-focused mutual-help groups (DFGs).</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>Using a cohort cyclical turnover design, individuals with dual diagnoses beginning a new outpatient mental health treatment episode (N=287) entered a standard- or an intensive-referral condition. Participants provided self-reports of 12-step mutual-help (DFG and substance-focused group [SFG]) attendance and involvement and substance use and psychiatric symptoms at baseline and six-month follow-up. The intensive referral intervention focused on encouraging patients to attend DFG meetings.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Compared to patients in the standard condition, those in the intensive referral intervention were more likely to attend and be involved in DFGs and SFGs, and had less drug use and better psychiatric outcomes at follow-up. Attending more intensive-referral sessions was associated with more DFG and SFG meeting attendance. More need fulfillment in DFGs, and more readiness to participate in SFGs, were associated with better alcohol and psychiatric outcomes at six months. However, only 23% of patients in the intensive-referral group attended a DFG meeting during the six-month follow-up period.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>The intensive referral intervention enhanced participation in both DFGs and SFGs and was associated with better six-month outcomes. The findings suggest that intensive referral to mutual-help groups focus on its key components (e.g., linking patients to 12-step volunteers) rather than type of group.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21515004</PMID>
<DateCompleted><Year>2012</Year>
<Month>02</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>12</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0046</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>118</Volume>
<Issue>2-3</Issue>
<PubDate><Year>2011</Year>
<Month>Nov</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Drug and alcohol dependence</Title>
<ISOAbbreviation>Drug Alcohol Depend</ISOAbbreviation>
</Journal>
<ArticleTitle>Intensive referral to 12-step dual-focused mutual-help groups.</ArticleTitle>
<Pagination><MedlinePgn>194-201</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.drugalcdep.2011.03.019</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study implemented and evaluated procedures to help clinicians effectively refer dually diagnosed (substance use and psychiatric disorders) patients to dual-focused mutual-help groups (DFGs).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Using a cohort cyclical turnover design, individuals with dual diagnoses beginning a new outpatient mental health treatment episode (N=287) entered a standard- or an intensive-referral condition. Participants provided self-reports of 12-step mutual-help (DFG and substance-focused group [SFG]) attendance and involvement and substance use and psychiatric symptoms at baseline and six-month follow-up. The intensive referral intervention focused on encouraging patients to attend DFG meetings.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared to patients in the standard condition, those in the intensive referral intervention were more likely to attend and be involved in DFGs and SFGs, and had less drug use and better psychiatric outcomes at follow-up. Attending more intensive-referral sessions was associated with more DFG and SFG meeting attendance. More need fulfillment in DFGs, and more readiness to participate in SFGs, were associated with better alcohol and psychiatric outcomes at six months. However, only 23% of patients in the intensive-referral group attended a DFG meeting during the six-month follow-up period.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The intensive referral intervention enhanced participation in both DFGs and SFGs and was associated with better six-month outcomes. The findings suggest that intensive referral to mutual-help groups focus on its key components (e.g., linking patients to 12-step volunteers) rather than type of group.</AbstractText>
<CopyrightInformation>Published by Elsevier Ireland Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Timko</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Center for Health Care Evaluation, Department of Veterans Affairs Health Care System, and Stanford University Medical Center, 795 Willow Road (152-MPD), Menlo Park, CA 94025, USA. ctimko@stanford.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sutkowi</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cronkite</LastName>
<ForeName>Ruth C</ForeName>
<Initials>RC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Makin-Byrd</LastName>
<ForeName>Kerry</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Moos</LastName>
<ForeName>Rudolf H</ForeName>
<Initials>RH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2011</Year>
<Month>04</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Ireland</Country>
<MedlineTA>Drug Alcohol Depend</MedlineTA>
<NlmUniqueID>7513587</NlmUniqueID>
<ISSNLinking>0376-8716</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015928" MajorTopicYN="N">Cognitive Behavioral Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017831" MajorTopicYN="N">Diagnosis, Dual (Psychiatry)</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012657" MajorTopicYN="Y">Self-Help Groups</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year>
<Month>11</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2011</Year>
<Month>03</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2011</Year>
<Month>03</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>4</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>4</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>2</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21515004</ArticleId>
<ArticleId IdType="pii">S0376-8716(11)00145-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.drugalcdep.2011.03.019</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><noCountry><name sortKey="Cronkite, Ruth C" sort="Cronkite, Ruth C" uniqKey="Cronkite R" first="Ruth C" last="Cronkite">Ruth C. Cronkite</name>
<name sortKey="Makin Byrd, Kerry" sort="Makin Byrd, Kerry" uniqKey="Makin Byrd K" first="Kerry" last="Makin-Byrd">Kerry Makin-Byrd</name>
<name sortKey="Moos, Rudolf H" sort="Moos, Rudolf H" uniqKey="Moos R" first="Rudolf H" last="Moos">Rudolf H. Moos</name>
<name sortKey="Sutkowi, Anne" sort="Sutkowi, Anne" uniqKey="Sutkowi A" first="Anne" last="Sutkowi">Anne Sutkowi</name>
</noCountry>
<country name="États-Unis"><region name="Californie"><name sortKey="Timko, Christine" sort="Timko, Christine" uniqKey="Timko C" first="Christine" last="Timko">Christine Timko</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/WillowV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001562 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001562 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= WillowV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:21515004 |texte= Intensive referral to 12-step dual-focused mutual-help groups. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21515004" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a WillowV1
![]() | This area was generated with Dilib version V0.6.37. | ![]() |